Evidence map›Paper›PMID 37854703›Full record

ArticleiScience2023

Absence of Embigin accelerates hearing loss and causes sub-viability, brain and heart defects in C57BL/6N mice due to interaction with

Sherylanne Newton, Carlos Aguilar, Rosie K Bunton-Stasyshyn, Marisa Flook, Michelle Stewart, Walter Marcotti, Steve Brown, Michael R Bowl

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. IMPC impact on preclinical mouse models.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sherylanne NewtonMammalian Genetics Unit, Medical Research Council Harwell Institute, Harwell Oxford, Oxfordshire OX11 0RD, UK.
Carlos AguilarMammalian Genetics Unit, Medical Research Council Harwell Institute, Harwell Oxford, Oxfordshire OX11 0RD, UK.
Rosie K Bunton-StasyshynThe Mary Lyon Centre, Medical Research Council Harwell Institute, Oxford, Oxfordshire OX11 0RD, UK.
Marisa FlookUCL Ear Institute, University College London, 332 Gray's Inn Road, London WC1X 8EE, UK.
Michelle StewartThe Mary Lyon Centre, Medical Research Council Harwell Institute, Oxford, Oxfordshire OX11 0RD, UK.
Walter MarcottiSchool of Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK.
Steve BrownMammalian Genetics Unit, Medical Research Council Harwell Institute, Harwell Oxford, Oxfordshire OX11 0RD, UK.
Michael R BowlMammalian Genetics Unit, Medical Research Council Harwell Institute, Harwell Oxford, Oxfordshire OX11 0RD, UK.
Mary Lyon Centre at MRC Harwell · GBMedical Research Council · GBUniversity College London · GBUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mouse studies continue to help elaborate upon the genetic landscape of mammalian disease and the underlying molecular mechanisms. Here, we have investigated an

Indexed as

Developmental geneticsModel organismNeurogeneticsPhenotyping

Identifiers

PMID37854703
PMCPMC10579432
OpenAlexW4387004801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.